A continued strong recovery in the important China and US markets means group revenues are expected to be significantly ahead of expectations. The strong revenue performance and improving gross margins has also delivered EBITDA significantly ahead of consensus expectations. The outlook remains robust, supported by ongoing recovery in China in particular and a strong order book gives good visibility over H1’21 revenues. We prudently leave outer year forecasts unchanged for now, but view the sensi ....
10 Jun 2020
Positive FY20 update – significant revenue beat
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Positive FY20 update – significant revenue beat
ECO Animal Health Group plc (EAH:LON) | 94.0 0 0.0% | Mkt Cap: 63.7m
- Published:
10 Jun 2020 -
Author:
Chris Glasper -
Pages:
3
A continued strong recovery in the important China and US markets means group revenues are expected to be significantly ahead of expectations. The strong revenue performance and improving gross margins has also delivered EBITDA significantly ahead of consensus expectations. The outlook remains robust, supported by ongoing recovery in China in particular and a strong order book gives good visibility over H1’21 revenues. We prudently leave outer year forecasts unchanged for now, but view the sensi ....